Noticias de ARGX_US

Mercado

Noticias del mercado

Últimas noticias sobre ARGX_US — 378 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ARGX_US ✕ 378 resultados
09/10/2026 ARGX_US — StreetInsider
H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)
09/10/2026 ARGX_US — StreetInsider
Truist Securities keeps Buy rating on argenx after trial failure, 'We believe the stock reaction is overdone'
09/10/2026 ARGX_US — Investing.com
Why is argenx stock rallying today? By Investing.com
09/10/2026 ARGX_US — MarketScreener
Argenx regains ground, Orange loses steam
09/10/2026 ARGX_US — Investing.com
Why is argenx stock rallying today? By Investing.com
09/10/2026 ARGX_US — Seeking Alpha
argenx: The Sjögren's Selloff Looks Overdone (NASDAQ:ARGX)
09/10/2026 ARGX_US — Zacks
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
09/10/2026 ARGX_US — MarketScreener
Argenx SE : Buy rating from DZ Bank
09/10/2026 ARGX_US — Investing.com
Why is argenx stock rallying today?
09/10/2026 ARGX_US — Yahoo Finance
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
09/10/2026 ARGX_US — MarketScreener
Argenx SE : Bernstein reiterates its Buy rating
09/10/2026 ARGX_US — Morningstar
Argenx: Vyvgart Disappointment in Sjogren's Overshadows Emerging FB102 Growth Platform
09/10/2026 ARGX_US — The Globe and Mail
Argenx Se (ARGX) Receives a Buy from RBC Capital

Detailed price information for Argenx Se ADR (ARGX-Q) from The Globe and Mail including charting and trades.

09/10/2026 ARGX_US — The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Edgewise Therapeutics (EWTX)

Detailed price information for Argenx Se ADR (ARGX-Q) from The Globe and Mail including charting and trades.

09/10/2026 ARGX_US — Investing.com
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
09/10/2026 ARGX_US — Yahoo Finance
argenx SE (ARGX) Stock Forecasts

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

09/10/2026 ARGX_US — GuruFocus
argenx (ARGX) Halts Phase 3 UNITY Trial for Sjogren's Disease Fo
08/10/2026 ARGX_US — GuruFocus
CEUX:ARGXB ROC (Joel Greenblatt) %: 166.08%
08/10/2026 ARGX_US — Yahoo Finance
ARGX Stock Sinks as Argenx Scraps Late-Stage Trial

Argenx shares sink as the company discontinues a Phase 3 trial of Vyvgart in Sjögren’s disease. Is the selloff an opportunity for long-term investors?

08/10/2026 ARGX_US — Barchart.com
ARGX Stock Sinks as Argenx Scraps Late-Stage Trial

Página 7 de 19